ORX-101

N/A

Report date: 2022/01/14 13:23:58
NME

Base Information

Drug NameORX-101
Drug Alias NameORX-101
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionIntegrin alpha 3/beta 1 inhibitorsP-glycoprotein 1 inhibitors
TargetsIntegrin alpha 3/beta 1P-glycoprotein 1
Therapy Area/IndicationsDiffuse Intrinsic Pontine Glioma
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesB&G Partners
China Registration ClassN/A

Develop Information

Inactive CompaniesN/A
Active IndicationsDiffuse Intrinsic Pontine Glioma
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A